Annual report pursuant to Section 13 and 15(d)

Restatement of Previously Issued Financial Statements (Tables)

v3.22.2
Restatement of Previously Issued Financial Statements (Tables)
 12 Months Ended
Dec. 31, 2021
Condensed Financial Information Disclosure [Abstract]  
Schedule of adjustments on the restated financial statements consolidated balance sheet
Consolidated Balance Sheet as of December 31, 2021   As
Previously Reported		     Adjustment     As Restated  
Accounts payable and accrued liabilities   $ 63,453     $ 11,550     $ 75,003  
Total liabilities   $ 258,304     $ 11,550     $ 269,854  
Additional paid-in capital   $ 708,175     $ (6,941 )   $ 701,234  
Accumulated deficit   $ (465,264 )   $ (4,609 )   $ (469,873 )
Total stockholders’ equity   $ 233,234     $ (11,550 )   $ 221,684  

 
Schedule of adjustments on the restated financial statements consolidated statement of cash flows
Consolidated Statement of Operations for the Year Ended December 31, 2021   As
Previously
Reported		     Adjustment     As Restated  
    (amounts in thousands except per share amounts)  
Change in fair value of contingent consideration from mergers and acquisitions   $ 6,229     $ 4,609     $ 10,838  
Total operating expenses   $ 335,930     $ 4,609     $ 340,539  
Net loss before income taxes   $ (164,819 )   $ (4,609 )   $ (169,428 )
Net loss   $ (164,875 )   $ (4,609 )   $ (169,484 )
Net loss attributable to common shareholders   $ (134,923 )   $ (4,609 )   $ (139,532 )
Net loss per share, basic and diluted   $ (1.39 )   $ (0.05 )   $ (1.44 )

 
Schedule of adjustments on the restated financial statements consolidated statement of cash flows
Consolidated Statement of Cash Flows for the Year Ended December 31, 2021   As
Previously
Reported		     Adjustment     As Restated  
Net loss   $ (164,875 )   $ (4,609 )   $ (169,484 )
Change in fair value of contingent consideration from mergers and acquisitions   $ 6,229     $ 4,609     $ 10,838